PCN88 AN ECONOMIC EVALUATION OF RITUXIMAB VERSUS OTHER FIRST-LINE TREATMENTS FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN POLAND
Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74339-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)74339-4/fulltext
Section Title :
Section Order :
263
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74339-4&doi=10.1016/S1098-3015(10)74339-4